Report #2862968

Received Oct 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 64 yrs
State: MA
Recovered: Unknown
Vaccinated: Sep 22, 2025
Onset: Sep 22, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	3E27G	—

Symptoms (1)

Product preparation issue

Symptom narrative

Shingrix adjuvant alone administration; Shingrix adjuvant alone administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 3E27G, expiry date 28-APR-2027) for prophylaxis. On 22-SEP-2025, the patient received Shingrix. On 22-SEP-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Shingrix adjuvant alone administration) and inappropriate dose of vaccine administered (Verbatim: Shingrix adjuvant alone administration). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 22-SEP-2025 A Registered nurse enquired about the procedure to follow after the administration of adjuvant alone of Shingrix to a patient.